Cite

HARVARD Citation

    Packer, L. et al. (n.d.). Combination of BGJ398 with either a pan-PI3K inhibitor or a specific PIK3CA inhibitor shows synergy in FGFR2 mutant endometrial cancer cell lines. European journal of cancer. pp. S148-. [Online]. 
  
Back to record